DOI: 10.1055/s-00033990

TH Open

Issue 02 · Volume 08 · April 2024 DOI: 10.1055/s-014-59426

Editorial

Letter to the Editor

e177
Verstraete, Andreas; Freson, Kathleen; Verhamme, Peter; Vanassche, Thomas: Thrombophilia Testing: from Genetic Predisposition to Discrimination

Original Article

e181
Chowdary, Pratima; Ofori-Asenso, Richard; Nissen, Francis; Grazzi, Enrico F.; Aizenas, Martynas; Moreno, Katya; Burke, Tom; Nolan, Beatrice; O'Hara, Jamie; Khair, Kate: Disease Burden, Clinical Outcomes, and Quality of Life in People with Hemophilia A without Inhibitors in Europe: Analyses from CHESS II/CHESS PAEDs
e209
Goldin, Mark; Smith, Kolton; Koulas, Ioannis; Leung, Tungming; Ravi, Mayuri; Parhar, Sanjit; Shah, Sejal; Floyd, Kayla; Ohanesian, Lori; Bain, Rachel; Defonte, Daniella; Ochani, Kanta; Lin, Amanda; Patel, Bhumi; Tsaftaridis, Nikolaos; Jnani, Jack; Spyropoulos, Alex C.: Clinical Pathways and Outcomes of Andexanet Alfa Administration for the Reversal of Critical Bleeding in Patients on Oral Direct Factor Xa Inhibitors
e216
Chan, Melissa; Yoon, Joshua; Telford, Jennifer J.; Drury, Chipman T.; Wan, Tony: Periprocedural Anticoagulation Management of Patients Undergoing Colonoscopy with Polypectomy
e232
Zou, Jinmi; Sun, Siyu; De Simone, Ilaria; ten Cate, Hugo; de Groot, Philip G.; de Laat, Bas; Roest, Mark; Heemskerk, Johan W.M.; Swieringa, Frauke: Platelet Activation Pathways Controlling Reversible Integrin αIIbβ3 Activation
e243
Leebeek, Frank W.G.; Castaman, Giancarlo; Marier, Jean François; Özen, Gülden; Bhattacharya, Indranil; Zhang, Jingmei; Wang, Scarlett; Wang, Yi: Exposure–Response Relationship between VWF/FVIII Activity and Spontaneous Bleeding Events Following Recombinant VWF Prophylaxis in Severe VWD

Review Article

e194
Jiménez-Yuste, Víctor; Álvarez-Román, María T.; Berrueco, Rubén; Bonanad, Santiago; Calvo-Villas, José M.; González-González, Rebeca; Porras, José R. González; Núñez-Vázquez, Ramiro J.; Rodríguez-López, Manuel: Management of Urgent Bleeding in Patients with Hemophilia A: Focus on the Use of Emicizumab